two
hundr
sixtyseven
patient
fulfil
cdc
case
definit
suspect
probabl
sar
admit
isol
ward
princess
margaret
hospit
februari
march
rtpcr
npa
becam
avail
us
midmarch
includ
studi
patient
nasopharyng
rtpcr
perform
ill
onset
routin
hematolog
biochem
microbiolog
test
perform
patient
npa
sampl
examin
rapid
immunofluoresc
antigen
detect
method
viral
cell
cultur
common
respiratori
viru
includ
influenza
virus
b
adenoviru
respiratori
syncyti
viru
parainfluenza
viru
type
sputum
sampl
screen
bacteri
mycobacteri
infect
convent
microscop
identif
gram
stain
acidfast
stain
cultur
method
blood
chocol
macconkey
media
serolog
test
mycoplasma
pneumonia
chlamydia
pneumonia
c
psittaci
perform
urinari
antigen
detect
test
use
detect
legionella
pneumophila
streptococcu
pneumonia
patient
pair
serum
sampl
taken
day
apart
assess
serolog
respons
coronaviru
immunofluoresc
assay
ifa
chest
radiograph
classifi
accord
later
extent
involv
npa
sampl
collect
patient
ad
steril
vial
contain
ml
viral
transport
medium
transport
ice
public
health
laboratori
centr
govern
virolog
unit
gvu
hong
kong
total
rna
npa
sampl
extract
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
instruct
manufactur
elut
buffer
total
elut
rna
reversetranscrib
use
revers
transcriptas
appli
biosystem
foster
citi
ca
reaction
contain
final
concentr
random
hexam
mixtur
incub
room
temperatur
min
min
reaction
stop
min
chill
ice
primer
use
amplif
target
coronaviru
polymeras
gene
design
gvu
sens
cac
cgt
ttc
tac
agg
tta
gct
aac
ga
antisens
aaa
tgt
tta
cgc
agg
taa
gcg
taa
aa
expect
product
size
bp
five
microlit
cdna
amplifi
master
mixtur
contain
pcr
buffer
amersham
pharmacia
biotech
piscataway
nj
mm
extra
deoxynucleosid
triphosph
dntp
mm
primer
taq
polymeras
uml
molecular
grade
water
one
posit
control
one
neg
control
includ
pcr
assay
reaction
perform
thermocycl
geneamp
pcr
system
appli
biosystem
follow
condit
min
follow
cycl
min
min
pcr
product
analyz
gel
electrophoresi
patient
receiv
treatment
accord
standard
protocol
either
plu
inhibitor
thirdgener
cephalosporin
combin
macrolid
fluoroquinolon
given
patient
admiss
per
recommend
hospit
author
hong
kong
antivir
drug
ribavirin
mgkgday
intraven
togeth
hydrocortison
mgkgday
administ
symptom
respond
within
h
recommend
found
avail
url
http
wwwhaorghkhkhesdnsapi
mlvalhaviewcont
lang
howev
recommend
sinc
chang
avail
url
http
wwwhaorghkhesdnsapi
mivalhaviewcont
hesdlang
methylprednisolon
form
two
three
puls
dose
mg
mg
day
intraven
administ
persist
fever
radiolog
evid
progress
lung
infiltr
sign
respiratori
distress
despit
initi
antiviralhydrocortison
combin
bivari
analysi
perform
epidemiolog
clinic
laboratori
radiolog
data
outcom
use
rtpcr
result
depend
variabl
data
continu
variabl
express
mean
standard
deviat
chisquar
test
use
categor
variabl
unpair
student
test
perform
continu
variabl
signific
factor
death
p
valu
pool
multivari
logist
regress
model
backward
stepwis
analysi
identifi
independ
predictor
clinic
outcom
p
valu
twotail
assum
statist
signific
analys
perform
spss
version
softwar
spss
inc
chicago
il
admiss
nasopharyng
rtpcr
perform
male
femal
patient
mean
age
year
patient
except
six
chines
two
indonesian
four
filipino
twentyon
patient
healthcar
worker
includ
clinician
nurs
ward
assist
alli
health
worker
work
sar
ward
fortyon
patient
report
recent
travel
sarsendem
area
week
admiss
common
area
visit
southern
part
china
cohort
consist
patient
local
hous
estat
amoy
garden
ten
patient
one
coexist
medic
problem
diabet
mellitu
case
histori
cerebrovascular
diseas
case
ischem
heart
diseas
case
chronic
rheumat
heart
diseas
case
hypertroph
obstruct
cardiomyopathi
case
sick
sinu
syndrom
case
cirrhosi
liver
secondari
chronic
hepat
b
case
bronchiectasi
case
endstag
renal
diseas
case
syndrom
case
nasopharyng
carcinoma
case
proport
patient
amoy
garden
rtpcr
posit
neg
significantli
differ
p
likewis
proport
healthcar
worker
p
patient
coexist
condit
p
differ
significantli
npa
sampl
rtpcr
taken
patient
admiss
sampl
patient
posit
mean
time
diseas
onset
sampl
collect
day
signific
differ
mean
sampl
time
found
patient
optim
time
sampl
collect
day
patient
posit
figur
common
clinic
featur
case
includ
fever
chill
malais
myalgia
cough
rigor
headach
tabl
short
breath
dizzi
significantli
higher
patient
bivari
analysi
vital
sign
taken
admiss
temperatur
heart
rate
systol
diastol
blood
pressur
similar
two
group
common
laboratori
find
includ
anemia
hemoglobin
level
gdl
lymphopenia
leukocyt
count
x
thrombocytopenia
platelet
count
x
hypokalemia
plasma
potassium
level
mmoll
hyponatremia
plasma
sodium
level
mmoll
elev
level
lactat
dehydrogenas
ul
alanin
transaminas
ul
creactiv
protein
bivari
analysi
lymphopenia
elev
lactat
dehydrogenas
level
admiss
significantli
differ
patient
tabl
eightyseven
npa
patient
patient
serolog
test
pair
serum
sampl
day
apart
posit
rtpcr
patient
patient
total
antibodi
detect
ifa
serolog
test
patient
group
posit
result
patient
group
patient
group
neg
initi
chest
radiograph
patient
abnorm
sixtyf
patient
patient
bilater
chest
involv
shown
radiograph
multifoc
radiolog
involv
found
patient
patient
bivari
analysi
patient
less
like
abnorm
bilater
p
multifoc
p
radiograph
overal
mortal
rate
patient
fiftytwo
patient
requir
intensivecar
unit
icu
admiss
patient
need
mechan
ventil
nine
patient
acut
renal
failur
complic
sar
compar
patient
patient
like
need
treatment
icu
p
requir
mechan
ventil
p
die
p
tabl
admiss
paramet
includ
epidemiolog
data
vital
sign
laboratori
chest
radiograph
find
analyz
separ
bivari
analysi
factor
associ
death
age
p
male
sex
p
major
coexist
medic
condit
p
short
breath
p
total
leukocyt
count
x
p
bilater
chest
radiograph
involv
p
rtpcr
posit
npa
sampl
p
puls
dose
steroid
p
multivari
analysi
independ
predictor
mortal
rtpcr
posit
npa
sampl
odd
ratio
confid
interv
ci
p
short
breath
admiss
ci
p
presenc
import
coexist
condit
ci
p
total
leukocyt
count
x
ci
p
puls
dose
methylprednisolon
ci
p
tabl
gener
epidemiolog
background
clinic
present
laboratori
find
radiolog
find
patient
similar
report
clinic
featur
cohort
rather
nonspecif
fever
chill
malais
myalgia
common
radiolog
featur
patient
similarli
nonspecif
anemia
lymphopenia
thrombocytopenia
common
admiss
symptom
might
reflect
peripher
consumpt
bone
marrow
suppress
infect
elev
alanin
transaminas
creactiv
protein
lactat
dehydrogenas
level
frequent
observ
find
might
indic
extens
tissu
damag
current
definit
sar
mainli
clinic
diagnosi
made
exclus
pneumonia
known
causal
agent
howev
patient
similar
clinic
scenario
may
infect
agent
place
locat
may
spread
infect
unfortun
isol
everi
patient
possibl
especi
larg
cohort
earli
rapid
reliabl
test
need
coronaviru
recogn
put
agent
sar
diagnost
test
burgeon
rapidli
past
month
howev
serolog
test
offer
earli
diagnosi
sinc
despit
remark
specif
requir
approxim
week
total
antibodi
becom
detect
electron
microscopi
viral
cultur
sensit
conveni
enough
gener
use
inevit
clinic
characterist
use
sole
diagnosi
sar
despit
condit
nonspecif
natur
rtpcr
coronaviru
npa
sampl
appear
best
support
test
earli
firm
diagnosi
howev
sensit
test
vari
standard
test
unifi
test
use
qualit
good
sensit
studi
mean
time
onset
symptom
sampl
collect
day
peiri
et
al
report
sensit
rtpcr
mean
day
onset
studi
best
time
sampl
day
onset
symptom
period
sampl
posit
howev
sinc
condit
sar
patient
deterior
clinic
radiolog
time
wait
day
make
firm
diagnosi
plan
appropri
therapi
possibl
mean
time
sampl
collect
differ
significantli
patient
suggest
differ
outcom
two
group
could
explain
discrep
durat
symptom
admiss
whether
differ
primer
use
rtpcr
test
infect
anoth
agent
metapneumoviru
chlamydia
speci
could
also
contribut
discrep
sensit
known
peiri
et
al
report
sensit
stool
sampl
rtpcr
test
mean
day
studi
overal
posit
rate
howev
rt
pcr
perform
stool
specimen
diarrhea
develop
patient
inconsist
time
sampl
collect
might
also
contribut
low
posit
rate
patient
neg
rtpcr
result
npa
sampl
none
stool
sampl
posit
rtpcr
henc
rtpcr
stool
specimen
could
provid
earli
diagnosi
coronaviru
infect
cohort
patient
posit
rtpcr
result
admiss
advers
outcom
term
surviv
icu
care
assist
ventil
compar
patient
neg
rtpcr
result
therefor
patient
overwhelm
diseas
viral
shed
may
readili
detect
despit
satisfactori
sensit
demonstr
test
might
provid
inform
quantit
analysi
henc
neg
result
might
repres
low
viral
load
patient
vice
versa
quantit
rtpcr
could
give
us
idea
correl
viral
concentr
diseas
progress
peiri
et
al
report
maxim
viral
replic
quantit
rtpcr
occur
approxim
day
clinic
worsen
seem
lag
behind
peak
although
could
quantifi
maxim
viral
shed
maxim
rtpcr
posit
fall
approxim
day
peiri
et
al
also
demonstr
initi
posit
rtpcr
result
correl
develop
acut
respiratori
distress
syndrom
multivari
analysi
model
howev
initi
rtpcr
posit
npa
independ
predictor
wors
outcom
rather
previous
report
factor
coexist
condit
although
quantit
rtpcr
perform
sampl
patient
sinc
test
avail
time
qualit
rtpcr
result
might
alert
clinician
watch
possibl
clinic
deterior
especi
former
test
infanc
common
use
relationship
viral
load
npa
outcom
investig
clinic
outcom
patient
wors
gener
compar
patient
chest
radiograph
show
bilater
multifoc
hazi
higher
level
lactat
dehydrogenas
observ
patient
might
indic
extens
lung
tissu
injuri
indic
sar
patient
poor
outcom
whether
lower
lymphocyt
count
patient
suggest
extens
viral
infect
remain
clarifi
use
puls
dose
methylprednisolon
could
result
clinic
improv
resolut
radiolog
infiltr
patient
howev
immunosuppress
effect
could
also
predispos
patient
secondari
nosocomi
infect
subsequ
death
handl
neg
result
rtpcr
test
problem
accord
world
health
organ
recommend
neg
result
least
two
possibl
first
may
indic
falseneg
result
caus
low
viral
load
inappropri
time
sampl
collect
second
anoth
infecti
noninfecti
agent
may
caus
sar
instead
coronaviru
final
neg
rtpcr
result
admiss
may
indic
earli
elimin
viru
effect
harmoni
immunolog
respons
serolog
test
thu
import
identifi
sar
infect
although
diagnosi
could
made
earli
enough
prompt
appropri
action
patient
rtpcr
serolog
result
concord
sensit
rtpcr
test
antibodi
test
use
standard
explain
variat
techniqu
time
sampl
optim
time
rtpcr
test
unknown
problem
find
appropri
sampl
time
taken
account
patient
neg
serolog
result
sinc
suggest
antibodi
could
detect
day
instead
day
cohort
addit
pcr
test
may
overli
sensit
may
advis
clinician
confirm
posit
rtpcr
result
repeat
test
origin
sampl
test
sampl
secondari
laboratori
increas
specif
result
rtpcr
antibodi
test
neg
eight
patient
patient
sign
symptom
clinic
radiolog
biochem
wellmatch
sar
given
treatment
includ
ribavirin
steroid
puls
dose
steroid
also
use
two
patient
addit
sampl
time
patient
could
repres
milder
spectrum
diseas
littl
antibodi
stimul
inconspicu
coronaviru
rna
level
simpli
infect
coronaviru
antibodi
product
may
suppress
steroid
administr
rtpcr
test
standard
test
still
vari
sensit
specif
still
confront
clinic
dilemma
term
infect
control
manag
furthermor
controversi
medic
manag
sar
never
settl
current
treatment
guidelin
propos
hospit
author
hong
kong
still
use
despit
advers
effect
suggest
treatment
recommend
found
avail
url
http
wwwhaorghkhkhesdnsapi
mlvalhaviewcont
lang
without
reliabl
rapid
rtpcr
test
diagnosi
patient
mislabel
sar
offer
treatment
need
result
indic
posit
nasopharyng
rtpcr
result
admiss
current
standard
rais
possibl
sar
appropri
clinic
set
alert
clinician
possibl
clinic
deterior
patient
furthermor
clinician
consid
repeat
qualit
rtpcr
test
perform
quantit
rtpcr
test
previous
patient
drug
treatment
group
patient
may
withheld
delay
especi
effect
reliabl
treatment
found
